Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 133 for “"Amorphous Solid Dispersions"”.

  1. Dissolution Behavior of Amorphous Solid Dispersions

    … drug. Solubility enhancement techniques, such as amorphous solid dispersions (ASDs), can be used in oral dosage forms to increase the apparent solubility of the drug in the gastrointestinal tract thus increasing the bioavailability of the drug. However, the drug solution generated from the …

    purdue-thes Repository record for Dissolution Behavior of Amorphous Solid Dispersions (opens in a new tab)

  2. Expanding the processing space for amorphous solid dispersions

    Amorphous solid dispersions are an effective formulation approach to enhance the solubility of the increasing number of poorly water-soluble drugs in development pipelines. The two most common formulation technologies to produce amorphous solid dispersions are hot-melt extrusion and spray drying, …

    texas Repository record for Expanding the processing space for amorphous solid dispersions (opens in a new tab)

  3. Thermodynamic And Kinetic Stabilization Of Amorphous Solid Dispersions

    … However, the higher free energy of the amorphous form, compared to its crystalline counterpart, could lead to crystallization, negating its solubility advantage. Molecularly dispersing a drug in a polymeric matrix could kinetically freeze it and slow down crystallization. Since …

    umn Repository record for Thermodynamic And Kinetic Stabilization Of Amorphous Solid Dispersions (opens in a new tab)

  4. Hydration-induced phase separation in amorphous solid dispersions

    Amorphous solid dispersions (ASDs) are pharmaceutical formulation in which a drug is molecularly dispersed within a carrier matrix. ASDs are designed to address the challenges of drugs with low solubility in their crystalline state. The carrier matrix, typically a polymer, stabilises the drug in …

    chalmers Repository record for Hydration-induced phase separation in amorphous solid dispersions (opens in a new tab)

  5. Dynamics and stabilization mechanisms of amorphous solid dispersions

    … make use of a formulation strategy known as an amorphous solid dispersion (ASD). The amorphous state of the pharmaceutical eliminates the impact of lattice energy resulting in increased solubility. However, since the pharmaceutical is in its thermodynamically metastable amorphous state, the …

    chalmers Repository record for Dynamics and stabilization mechanisms of amorphous solid dispersions (opens in a new tab)

  6. Dynamics and stabilization mechanisms of amorphous solid dispersions

    … make use of a formulation strategy known as an amorphous solid dispersion (ASD)13, 31. The amorphous state of the pharmaceutical eliminates the impact of lattice energy resulting in increased solubility. However, since the pharmaceutical is in its thermodynamically metastable amorphous state, …

    chalmers Repository record for Dynamics and stabilization mechanisms of amorphous solid dispersions (opens in a new tab)

  7. Processing impact on the performance of amorphous solid dispersions

    The level of understanding of amorphous solid dispersions has grown significantly in the last two decades. A number of commercial amorphous solid dispersions have been approved and they have become the industry norm for overcoming poor water-solubility when an enabling technology is necessary. …

    texas Repository record for Processing impact on the performance of amorphous solid dispersions (opens in a new tab)

  8. Thermokinetic processing of supersaturating and mucoadhesive amorphous solid dispersions

    Thermal processing of amorphous solid dispersions continues to gain interest in the pharmaceutical industry, as evident by several recently approved commercial products. Still, a number of pharmaceutical polymer carriers exhibit thermal or viscoelastic limitations in thermal processing, especially …

    texas Repository record for Thermokinetic processing of supersaturating and mucoadhesive amorphous solid dispersions (opens in a new tab)

  9. Predictive design of stable polymer-based amorphous solid dispersions

    The potential of amorphous solid dispersions (ASDs) solving current aqueous solubility challenges within the pharmaceutical industry has been extensively reported. Nonetheless, the difficulty of ensuring long-term physical stability has limited its translation into commercial drug products. One of …

    strathclyde Repository record for Predictive design of stable polymer-based amorphous solid dispersions (opens in a new tab)

  10. Crystallization Inhibition in High Drug Loaded Amorphous Solid Dispersions

    … additives on the crystallization propensity in amorphous solid dispersions (ASDs). Crystallization of amorphous drugs negates the solubility advantage compared to their crystalline counterparts. Therefore, a major task for developing robust ASDs is to understand and avoid crystallization. Though …

    umn Repository record for Crystallization Inhibition in High Drug Loaded Amorphous Solid Dispersions (opens in a new tab)

  11. The development of ritonavir and pyrimethamine amorphous solid dispersions

    … in the crystalline form and instability in the amorphous form. These two drugs were the two model drugs used in the testing of a screening of polymers for amorphous drug stabilisation (SPADS) method to produce and study pharmaceutical amorphous solid dispersions (PhASDs). Six different PhASDs …

    nwu-za Repository record for The development of ritonavir and pyrimethamine amorphous solid dispersions (opens in a new tab)

  12. The development of paracetamol and dapsone amorphous solid dispersions

    … increased, the focus turned to developing the amorphous form of the drug. Dapsone (DAP) is no exception, as this drug has poor aqueous solubility and dissolution rate profile. Paracetamol (PCA) is hydrophobic and can present with problematic equilibrium solubility. DAP is a bacteriostatic …

    nwu-za Repository record for The development of paracetamol and dapsone amorphous solid dispersions (opens in a new tab)

  13. The development of efavirenz and praziquantel amorphous solid dispersions

    … To increase the solubility of these drugs, amorphous forms can be created. The problem with amorphous forms is that they are unstable, whilst crystallisation is almost always a given. To increase the stability of these APIs, amorphous solid dispersions (ASD) are created by using polymers …

    nwu-za Repository record for The development of efavirenz and praziquantel amorphous solid dispersions (opens in a new tab)

  14. Characterization of the 3D nanostructure of amorphous solid dispersions

    … solubility is the formulation strategy of amorphous solid dispersions which are compound that consist of an amorphous drug dispersed in a polymer carrier. Despite successful pharmaceutical compounds being produced these systems are not fully understood, and their formulation are still …

    chalmers Repository record for Characterization of the 3D nanostructure of amorphous solid dispersions (opens in a new tab)

  15. Effect of molecular interactions on properties of amorphous solid dispersions

    Amorphous solid dispersions have been widely applied to improve the oral bioavailability of BCS Class II and Class IV compounds by increasing their kinetic solubility and dissolution rate. However, maintaining the amorphous state of drug substances in amorphous solid dispersions is a challenge, …

    texas Repository record for Effect of molecular interactions on properties of amorphous solid dispersions (opens in a new tab)

  16. Understanding Critical Parameters Affecting the Dissolution of Amorphous Solid Dispersions

    Amorphous solid dispersion (ASD) is one of the formulation techniques that attempts to address the delivery challenges associated with poorly water-soluble drugs. ASDs generate supersaturation in solution and often lead to increased absorption. However, the high energy nature of this strategy leads …

    toronto-retro Repository record for Understanding Critical Parameters Affecting the Dissolution of Amorphous Solid Dispersions (opens in a new tab)

  17. Evaluation and enhancement of physical stability of amorphous solid dispersions

    … of poorly water-soluble drugs.[1],[2] The amorphous forms of APIs have attracted considerable attention as the amorphous forms tend to exhibit significantly higher levels of supersaturation in aqueous media when compared to the crystalline forms.[3],[4] For drugs which bioavailability is …

    mississippi Repository record for Evaluation and enhancement of physical stability of amorphous solid dispersions (opens in a new tab)

  18. The development of sulfadoxine and nevirapine pharmaceutical amorphous solid dispersions

    Solid oral dosage forms are the most convenient and prevalent dosage form in the pharmaceutical industry although an estimated 90% of drugs currently in development can be classified as poorly soluble. These drugs will subsequently present with poor dissolution which can lead to inadequate …

    nwu-za Repository record for The development of sulfadoxine and nevirapine pharmaceutical amorphous solid dispersions (opens in a new tab)

  19. Insights on the Dissolution Evaluation and Optimization of Amorphous Solid Dispersions

    Amorphous solid dispersions (ASDs) are an attractive approach to enhance solubility and improve the dissolution of poorly soluble crystalline drugs in recent decades. In the ASDs, unlike the 3-dimensional long-range order for the crystalline form, the amorphous drug disperses with the polymer …

    ku Repository record for Insights on the Dissolution Evaluation and Optimization of Amorphous Solid Dispersions (opens in a new tab)

Page 1 of 7